SPRO Spero Therapeutics, Inc.

Fundamentals / CIK 0001701108 / USD

Spero Therapeutics, Inc. reported $41.55M in revenue and a net loss of $29.51M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a -67.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SPRO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$111.8M$55.88M$0-$92.78MFY 2016 Revenue: $335KFY 2016 Net Income: -$25.49M2016FY 2017 Revenue: $1.98MFY 2017 Net Income: -$38.74M2017FY 2018 Revenue: $3.97MFY 2018 Net Income: -$41.70M2018FY 2019 Revenue: $18.15MFY 2019 Net Income: -$60.90M2019FY 2020 Revenue: $9.33MFY 2020 Net Income: -$78.30M2020FY 2021 Revenue: $18.26MFY 2021 Net Income: -$89.80M2021FY 2022 Revenue: $53.51MFY 2022 Net Income: $46.41M2022FY 2023 Revenue: $103.8MFY 2023 Net Income: $22.81M2023FY 2024 Revenue: $47.98MFY 2024 Net Income: -$68.57M2024FY 2025 Revenue: $66.80MFY 2025 Net Income: $8.57M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $66.80M $47.98M $103.8M $53.51M $18.26M $9.33M $18.15M $3.97M $1.98M $335K
Research & Development $38.47M $96.76M $51.44M $47.59M $64.53M $67.00M $65.78M $33.88M $32.87M $26.33M
Total Operating Expenses $60.49M $121.3M $82.30M $95.71M $106.2M $88.44M $81.36M $46.77M $43.71M $33.56M
Operating Income $6.31M -$73.36M $21.48M -$42.20M -$87.97M -$79.11M -$63.22M -$42.81M -$41.73M -$33.22M
EBITDA $6.31M -$73.36M $21.85M -$41.33M -$87.33M -$78.35M -$62.47M -$42.40M -$41.37M -$32.94M
Interest Income $2.51M $4.74M $3.94M $1.11M $346K $401K $1.33M $1.10M -- --
Income Before Tax $8.83M -$68.57M $25.40M -$46.41M -$89.76M -$78.28M -$60.92M -$41.66M -$39.89M -$32.64M
Income Tax Expense $261K $0 $2.60M $0 $0 $0 $0 $0 $0 $0
Net Income $8.57M -$68.57M $22.81M $46.41M -$89.80M -$78.30M -$60.90M -$41.70M -$38.74M -$25.49M
Basic EPS $0.15 -$1.27 $0.43 -$1.23 -$2.91 -$3.52 -$3.35 -$2.60 -$17.82 -$95.87
Diluted EPS $0.15 -$1.27 $0.43 -$1.23 -$2.91 -$3.52 -$3.35 -$2.60 -$17.82 -$95.87
Basic Shares Outstanding 56.0M 54.0M 52.7M 37.6M 30.9M 22.4M 18.2M 16.0M 2.6M 312.2K
Diluted Shares Outstanding 59.0M 54.0M 53.0M 37.6M 30.9M 22.4M 18.2M 16.0M 2.6M 312.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $258K $41.30M $5.44M $14.19M $5.87M $15.04M
Research & Development $3.20M $3.43M $2.91M $5.59M $8.60M $10.67M $13.61M $28.84M
Total Operating Expenses $41.91M $9.93M $7.80M $9.89M $13.36M $16.63M $20.61M $36.77M
Operating Income -$41.91M -$9.93M -$7.54M $31.41M -$7.92M -$2.44M -$14.73M -$21.73M
EBITDA -- -- -- -- -- -- -- -$21.73M
Interest Income $912K $377K $336K $376K $532K $740K $864K $1.03M
Income Tax Expense -- -- -- -- $0 -- -- --
Net Income -$44.28M -$9.55M -$7.20M $31.52M -$7.38M -$1.70M -$13.87M -$20.89M
Basic EPS -$0.76 -$0.16 -$0.13 -- -$0.13 -$0.03 -$0.25 --
Diluted EPS -$0.76 -$0.16 -$0.13 -- -$0.13 -$0.03 -$0.25 --
Basic Shares Outstanding 58.2M 58.0M 57.3M -- 56.3M 56.0M 55.4M --
Diluted Shares Outstanding 58.2M 58.0M 57.3M -- 56.3M 56.0M 55.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $40.27M $52.89M $76.33M $109.1M $112.6M $85.21M $29.73M $34.08M $87.29M $10.31M
Short-Term Investments -- -- -- $0 $33.82M $41.70M $52.31M $81.36M -- --
Cash & Short-Term Investments $40.27M $52.89M $76.33M $109.1M $146.4M $126.9M $82.05M $115.4M $87.29M $10.31M
Other Current Assets $28K -- -- -- -- -- -- -- -- --
Total Current Assets $67.29M $107.3M $131.2M $113.6M $157.9M $139.1M $95.41M $124.2M $92.06M $11.87M
Property, Plant & Equipment, Net -- $0 $2.0K $368K $1.03M $1.67M $2.27M $2.89M $1.16M $1.50M
Other Non-Current Assets $153K $153K $435K $5.74M $5.64M $5.21M $3.52M $1.66M -- --
Total Non-Current Assets $1.63M $3.27M $51.18M $11.23M $13.20M $14.31M $10.69M $4.79M $1.42M $1.90M
Total Assets $68.92M $110.5M $182.4M $124.8M $171.1M $153.5M $106.1M $129.0M $93.48M $13.77M
Accounts Payable $693K $7.31M $1.38M $617K $1.10M $1.16M $4.15M $3.60M $3.47M $1.14M
Deferred Revenue (Current) $0 $368K $2.13M $4.15M $1.86M $0 -- -- -- --
Total Current Liabilities $8.87M $49.07M $37.15M $21.65M $18.67M $14.34M $26.66M $12.32M $8.16M $6.92M
Deferred Revenue (Non-Current) $0 $12.22M $10.82M $9.74M $8.79M -- -- -- -- --
Total Non-Current Liabilities $1.03M $15.35M $38.34M $27.22M $64.11M $7.07M $4.87M $833K $365K $493K
Total Liabilities $9.90M $64.42M $75.50M $48.87M $82.78M $21.41M $31.53M $13.15M $8.52M $7.41M
Total Debt (incl. Leases) $2.90M $4.30M $5.54M $6.65M $7.33M $7.84M $5.54M -- -- --
Common Stock $56K $55K $53K $52K $32K $29K $19K $17K $14K $0
Retained Earnings -$451.1M -$459.6M -$391.1M -$413.9M -$367.5M -$277.7M -$199.4M -$138.5M -$96.84M -$45.44M
Accumulated Other Comp. Income -- -- $0 $0 -$2.0K -$7.0K $16K -$28K -- --
Total Stockholders' Equity $59.02M $46.12M $106.9M $75.93M $88.29M $132.0M $74.57M $115.5M $84.60M -$45.44M
Total Equity $59.02M $46.12M $106.9M $75.93M $88.29M $132.0M $74.57M $115.9M $84.96M -$49.25M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $107.9M $50.77M $56.13M $40.27M $48.62M $31.19M $48.89M $52.89M
Cash & Short-Term Investments $107.9M $50.77M $56.13M $40.27M $48.62M $31.19M $48.89M $52.89M
Other Current Assets $12K $25K -- $28K -- -- -- --
Total Current Assets $109.2M $51.58M $57.61M $67.29M $52.32M $59.40M $74.71M $107.3M
Property, Plant & Equipment, Net -- -- -- -- -- -- -- $0
Other Non-Current Assets $0 $153K $153K $153K $153K $153K $153K $153K
Total Non-Current Assets $798K $1.18M $1.41M $1.63M $1.85M $2.72M $3.00M $3.27M
Total Assets $110.0M $52.77M $59.02M $68.92M $54.17M $62.12M $77.71M $110.5M
Accounts Payable $411K $155K $217K $693K $1.40M $780K $1.76M $7.31M
Deferred Revenue (Current) -- -- -- $0 $0 $0 $0 $368K
Total Current Liabilities $56.96M $8.43M $5.49M $8.87M $13.65M $14.95M $29.16M $49.07M
Deferred Revenue (Non-Current) -- -- -- $0 $12.57M $12.57M $12.57M $12.22M
Total Non-Current Liabilities $52.28M $134K $598K $1.03M $14.03M $14.35M $14.74M $15.35M
Total Liabilities $109.2M $8.56M $6.09M $9.90M $27.68M $29.29M $43.90M $64.42M
Total Debt (incl. Leases) $1.59M $2.04M $2.47M $2.90M $3.35M $3.62M $3.96M $4.30M
Common Stock $58K $58K $58K $56K $56K $56K $56K $55K
Retained Earnings -$512.1M -$467.8M -$458.3M -$451.1M -$482.6M -$475.2M -$473.5M -$459.6M
Total Stockholders' Equity $781K $44.20M $52.93M $59.02M $26.49M $32.83M $33.81M $46.12M
Total Equity $781K $44.20M $52.93M $59.02M $26.49M $32.83M $33.81M $46.12M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $8.57M -$68.57M $22.81M -$46.41M -$89.76M -$78.28M -$60.92M -$41.66M -$39.89M -$32.64M
Depreciation & Amortization $0 $2.0K $367K $869K $646K $761K $750K $409K $363K $279K
Stock-Based Compensation $4.33M $7.79M $7.93M $9.12M $9.43M $4.89M $3.78M $2.75M $1.43M $180K
Change in Payables -$6.61M $5.93M $761K -$484K -$53K -$2.98M $564K $84K $2.35M -$644K
Operating Cash Flow -$12.62M -$23.44M -$32.99M -$7.73M -$64.35M -$85.87M -$50.02M -$39.62M -$39.11M -$28.96M
Capital Expenditure -- -- -- -- -- -$157K -$314K -$2.44M -$27K -$830K
Free Cash Flow -- -- -- -- -- -$86.03M -$50.33M -$42.06M -$39.14M -$29.79M
Purchases of Investments -- -- $0 -$26.97M -$43.91M -$45.72M -$88.99M -$130.2M -- --
Investing Cash Flow -- -- $0 $33.81M $7.67M $10.47M $29.53M -$83.16M -$27K -$830K
Common Stock Issued -- $0 $221K -- $7.83M $13.17M $15.79M -- -- --
Financing Cash Flow -- $0 $221K -$29.55M $84.05M $130.9M $16.14M $69.52M $116.1M $34.41M
Net Change in Cash -$12.62M -$23.44M -$32.77M -$3.48M $27.38M $55.48M -$4.35M -$53.26M $76.97M $4.62M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$44.28M -$9.55M -$7.20M $31.52M -$7.38M -$1.70M -$13.87M -$20.89M
Depreciation & Amortization -- -- -- -- -- -- -- $0
Stock-Based Compensation $855K $822K $1.11M $1.01M $1.05M $714K $1.56M $1.50M
Change in Payables $256K -$62K -$476K -$702K $615K -$985K -$5.54M $1.22M
Operating Cash Flow -$42.61M -$5.36M $15.86M -$8.35M $17.42M -$17.69M -$4.00M -$23.40M
Net Change in Cash $57.15M -$5.36M $15.86M -$8.35M $17.42M -$17.69M -$4.00M -$23.40M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin 9.5% -152.9% 20.7% -78.9% -481.9% -847.9% -348.4% -1079.3% -2108.6% -9916.7%
Net Profit Margin 12.8% -142.9% 22.0% 86.7% -491.9% -839.2% -335.6% -1051.4% -1957.7% -7609.3%
Return on Equity (ROE) 14.5% -148.7% 21.3% 61.1% -101.7% -59.3% -81.7% -36.1% -45.8% --
Return on Assets (ROA) 12.4% -62.0% 12.5% 37.2% -52.5% -51.0% -57.4% -32.3% -41.4% -185.1%
Current Ratio 7.59x 2.19x 3.53x 5.25x 8.46x 9.70x 3.58x 10.08x 11.29x 1.72x
Quick Ratio 4.54x 1.08x 2.05x 5.04x 7.84x 8.85x 3.08x 9.37x 10.70x 1.49x
Debt to Equity 0.05x 0.09x 0.05x 0.09x 0.08x 0.06x 0.07x -- -- --
Revenue Growth (YoY) +39.2% -53.8% +94.0% +193.1% +95.7% -48.6% +357.6% +100.4% +490.7% --
Operating Income Growth (YoY) -- -441.5% -- -- -- -- -- -- -- --
Net Income Growth (YoY) -- -400.6% -50.9% -- -- -- -- -- -- --
EPS Growth (YoY) -- -395.3% -- -- -- -- -- -- -- --
5Y Revenue / Share Growth +186.1% -11.1% +694.5% +86.1% -44.9% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -67.3% 12.8% 22.1% 9.5% -115.5% -118.4% -166.2% -152.9%
Net Profit Margin -71.0% 15.7% 24.9% 12.8% -108.1% -110.3% -156.5% -142.9%
Return on Equity (ROE) -3778.9% 16.7% 28.8% 14.5% -165.5% -163.3% -206.3% -148.7%
Return on Assets (ROA) -26.8% 14.0% 25.8% 12.4% -80.9% -86.3% -89.8% -62.0%
Current Ratio 1.92x 6.12x 10.50x 7.59x 3.83x 3.97x 2.56x 2.19x
Quick Ratio 1.89x 6.02x 10.23x 4.54x 3.56x 2.09x 1.68x 1.08x
Debt to Equity 2.04x 0.05x 0.05x 0.05x 0.13x 0.11x 0.12x 0.09x
Revenue Growth (YoY) -100.0% -100.0% -95.6% +174.5% -59.6% +39.1% -36.6% -79.5%
Operating Income Growth (YoY) -- -- -- -- -- -- -- -143.0%
Net Income Growth (YoY) -- -- -- -- -- -- -- -140.8%
Operating Cash Flow Growth (YoY) -344.6% -- -- -- +36.5% -- -167.4% --
Source: SEC EDGAR CompanyFacts (CIK 0001701108) · from December 31, 2015 Data through September 30, 2026 · synced Nov 20, 2026, 05:52 UTC · Open in terminal